These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 6458525)

  • 41. [Comparative study of the "in vitro" sensitivity of cefoxitin and cephalosporins].
    Torres A; Aguirre M; Ales JM
    Rev Clin Esp; 1979 Nov; 155(4):249-52. PubMed ID: 542674
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 43. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sensitivity of nanoparticlized cefazolin sodium to the bacteria in vitro].
    Zou L; Fan XG; Gui H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):318-20. PubMed ID: 16045023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
    Rai R; Chen HN; Czyryca PG; Li J; Chang CW
    Org Lett; 2006 Mar; 8(5):887-9. PubMed ID: 16494466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins.
    Shah PM; Stille W
    J Antimicrob Chemother; 1983 Jun; 11(6):597-8. PubMed ID: 6350256
    [No Abstract]   [Full Text] [Related]  

  • 49. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The sensitivity of urinary isolates to cefuroxime, a new beta-lactamase stable cephalosporin.
    Roberts AP; Phillips R; Griffiths A; Sykes RB
    Curr Med Res Opin; 1980; 7(1):5-13. PubMed ID: 7428414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on the antibacterial activity of the combination cefazolin-dicloxacillin].
    Ripa S; Tarsi R; Orpianesi C; Prenna M
    Nuovi Ann Ig Microbiol; 1976; 27(3):265-76. PubMed ID: 1026925
    [No Abstract]   [Full Text] [Related]  

  • 52. Beta-lactamase resistance of cephazolin and other cephalosporins.
    Goodwin CS; Hill JP
    Scott Med J; 1976 Sep; 20(5):236-9. PubMed ID: 772808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative sensitivity of penicillinase producing Staphylococcus aureus to four cephalosporin antibiotics.
    Bremner DA; Fortune J
    N Z Med J; 1975 Sep; 82(548):189-90. PubMed ID: 1059959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO; Héraïef E
    Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
    [No Abstract]   [Full Text] [Related]  

  • 56. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
    Pulverer G; Peters G
    Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1994; 40(4):232-8. PubMed ID: 8082410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antibiotic resistance of pathogenic bacteria related to respiratory infections in children from Shanghai].
    Che DT; Lu M; Zhang H; Li WH; Lu Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):338-40. PubMed ID: 16923372
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunomodulating properties of newer cephalosporins: a preliminary classification.
    Labro M; Bryskier A
    Chemioterapia; 1987 Jun; 6(2 Suppl):219-21. PubMed ID: 3334561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.